Louis Brenner

Title: Louis Brenner: Innovator in Pharmaceutical Patents

Introduction

Louis Brenner is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative tablet formulations. With a total of 4 patents to his name, Brenner's work focuses on improving patient care through advanced medical solutions.

Latest Patents

One of Brenner's latest patents involves aliphatic amine polymer salts for tableting. This invention includes tablets, compositions, and methods that utilize a carbonate salt of an aliphatic amine polymer combined with a monovalent anion. These formulations are designed to prevent or ameliorate acidosis, especially in patients suffering from renal disease. The tablets maintain a disintegration time of no greater than 30 minutes at 37°C and at a pH of at least 1 for a period of at least ten weeks at 60°C. Furthermore, these tablets are stable for extended periods without requiring specialized storage conditions.

Career Highlights

Brenner's career is marked by his dedication to pharmaceutical innovation. He works at Genzyme Corporation, where he continues to develop groundbreaking solutions that address critical health issues. His expertise in polymer chemistry and tablet formulation has positioned him as a key player in the industry.

Collaborations

Throughout his career, Brenner has collaborated with several talented individuals, including Hitesh R Bhagat and Jeffrey M Goldberg. These partnerships have fostered a creative environment that encourages the development of innovative pharmaceutical products.

Conclusion

Louis Brenner's contributions to the field of pharmaceuticals through his patents and collaborations highlight his commitment to improving patient outcomes. His innovative work continues to pave the way for advancements in medical treatments.